about
Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotypeTolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cellsScrapie-specific pathology of sheep lymphoid tissues.Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virusA polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphomaA survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor.The transmissible spongiform encephalopathies: pathogenic mechanisms and strategies for therapeutic intervention.C-reactive protein and cardiovascular disease: new insights from an old molecule.Emerging therapeutic agents for transmissible spongiform encephalopathies: a review.Construction of a catsper1 DNA vaccine and its antifertility effect on male mice.Approaches to enhance the efficacy of DNA vaccines.T-cell regulation: with complements from innate immunity.Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus.Complement activation in progressive renal disease.Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.Production of complement components by cells of the immune system.Temporary blockade of the tumor necrosis factor receptor signaling pathway impedes the spread of scrapie to the brainFollicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibilityAntigen fusion with C3d3 augments or inhibits humoral immunity to AAV genetic vaccines in a transgene-dependent manner.A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases.Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb.Flavoxobin, a serine protease from Trimeresurus flavoviridis (habu snake) venom, independently cleaves Arg726-Ser727 of human C3 and acts as a novel, heterologous C3 convertase.Follicular dendritic cell dedifferentiation reduces scrapie susceptibility following inoculation via the skin.Leishmania immune adherence reaction in vertebrates.Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy.NF-κB2/p100 deficiency impairs immune responses to T-cell-independent type 2 antigens.
P2860
Q24293121-CFF3CAE0-068B-4874-ABB6-9B4CF5EF9C3FQ28565650-B8752BF4-5A16-406E-920E-501855ADB485Q33309951-25247724-2D9F-4A78-9E5D-83D9E7C53D85Q33920103-5E20FBF0-D446-4613-9D07-49B1DDCB628AQ34007430-DA2EBC79-E541-459B-B148-C988C7C8791DQ34356278-847A7D2A-59A6-4F42-A834-23F49C52B919Q35050425-5BC02B97-D608-4149-9DD7-6F49CEE59C80Q35562701-D8B73908-A569-4372-A051-6B13FB99EC55Q35591287-28D6A28A-F2EC-439B-9C92-19DF5C7F8691Q35620710-020828D8-DF7C-45A4-AE5A-E033F9903D49Q35743279-377685D5-A1EE-416F-BD0D-782112F8EF70Q36684909-EE6279DD-4207-4F35-AF30-C9672A39D305Q36960498-F9E0A227-CCE4-4363-9018-E9F6EF8B41FAQ38348940-1E28DD35-26E7-4CBA-9DC7-D0F0ADDF75F5Q38848896-956A14DE-5455-4E04-93B4-51F6FA185567Q38935414-6422E75B-FC5D-4DA3-8F43-E0A3122F61C4Q39683541-B74A651C-C340-470D-AA4C-F49CA3EDDDEAQ39756940-1A58995D-6B64-4E67-BAE3-1C5EAD45D34EQ39771124-9A049FDB-B51B-42C9-83CD-5CAB2CFBEF4DQ40625728-916D26E2-F47E-4B35-BBC6-D09E4BB9098DQ40770484-24AFB2F6-6B9A-4DA7-9920-26CBC7CD5072Q44133281-F18A0824-D5C5-424C-8B2F-0E530F576085Q45236202-E74E39BE-F82B-46C3-8018-1B69C082042CQ46443728-758BB460-7189-44FE-A89B-923909D120D9Q53191511-CD46AB76-E77C-44E4-9E29-E8C48979B382Q54586665-6CE41C07-6066-4303-8629-C72FA0181BBE
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
The role of complement in the acquired immune response.
@ast
The role of complement in the acquired immune response.
@en
type
label
The role of complement in the acquired immune response.
@ast
The role of complement in the acquired immune response.
@en
prefLabel
The role of complement in the acquired immune response.
@ast
The role of complement in the acquired immune response.
@en
P2093
P2860
P1433
P1476
The role of complement in the acquired immune response.
@en
P2093
C H Nielsen
E M Fischer
R G Leslie
P2860
P356
10.1046/J.1365-2567.2000.00009.X
P577
2000-05-01T00:00:00Z